PATENT CLAIM ANALYSIS

Application Number: 16301875
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "397000"]

Abstract:
The present invention relates to imidazole derivatives of Formula (I), wherein A, R, R 1 , and R 2  are as defined in the specification, pharmaceutical compositions containing such compounds and to their use in therapy.

Claim (Index 16):
The method of  claim 11 , wherein the glioblastoma is giant cell glioblastoma or gliosarcoma.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 98.0
- Lexical Diversity: 1.26471
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15508816', '14650292', '15314851', '15613361', '15610015']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7946782788827887
- 35 USC 102 Novelty (BERT): 0.5786692947502157
- Combined Prediction Score: 0.7730773804695314
- Mean Citation Score: 353.024622
- Max Citation Score: 540.6397
- Similarity Product: 365.6501555589497

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test